In the EU, a GMO is defined as an organism in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination.
Have look at the poster that ASPHALION experts prepared for the SETGYC congress about the “Regulatory requirements for genetically modified organism (GMO) applications: tips and tricks for global ATMP and vaccine development”.
Asphalion has participated in the following research projects funded by the European Union’s Horizon 2020 Research and Innovation programme: MISTRAL-HIV (No 847943), CardioReGenix (No 825670), RBDCOV (No 101046118), and UroPrint (No 964883); and on the Innovative Medicines Initiative 2 Joint Undertaking project ARDAT (No 945473), and on the Eurostars project Synchropace (ref. 115484 through the Innovative UK Project 600538).
For further information contact us at: [email protected]